| Dr Joseph D Ferrara, MD | |
|
5612 Easton Rd, Plumsteadville, PA 18949 | |
| (215) 766-8844 | |
| Not Available |
| Full Name | Dr Joseph D Ferrara |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 40 Years |
| Location | 5612 Easton Rd, Plumsteadville, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215925979 | NPI | - | NPPES |
| 1131357 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD037838E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doylestown Hospital Visiting Nurse/hcd | Doylestown, PA | Home health agency |
| Doylestown Hospital | Doylestown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Plumsteadville Family Practice | 9335138155 | 9 |
News Archive
Bristol-Myers Squibb Company, Gilead Sciences, Inc. and Merck & Co., Inc. have announced that they are in discussions on the development of a once-daily, fixed-dose combination of three anti-HIV drugs and are also considering certain co-packaging options for the individual products.
Today GE Healthcare officially opens Health Innovation Village, its first health tech startup campus, at its Finnish headquarters with the Minister of Economic Affairs in Finland, Jan Vapaavuori and the Mayor of Helsinki, Jussi Pajunen.
Sunwin International Neutraceuticals, Inc. ("Sunwin") (OTCBB: SUWN) - a worldwide supplier of all-natural, zero-calorie stevia, and WILD Flavors, Inc. ("WILD Flavors") - one of the largest, privately-owned suppliers of natural and health-enhancing ingredients, flavors, colors, and innovative product concepts to the food and beverage industry, have completed the process for U.S. Food and Drug Administration ("FDA") self-affirmed GRAS status for stevia extracts produced by Sunwin and sold worldwide.
As the opioid crisis escalates, the science behind addiction remains poorly understood. To address this need, researchers at University of Utah Health devised a system that allowed zebrafish, a small tropical fish, to self-administer doses of hydrocodone, an opioid commonly prescribed to people for pain.
An antibody drug that targets a surface marker on cancer stem cells could offer a promising new therapeutic approach for treating acute myeloid leukemia (AML), a form of blood cancer that affects an estimated 50,000 people in Saudi Arabia.
› Verified 2 days ago
| Entity Name | Plumsteadville Family Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275573503 PECOS PAC ID: 9335138155 Enrollment ID: O20040507000784 |
News Archive
Bristol-Myers Squibb Company, Gilead Sciences, Inc. and Merck & Co., Inc. have announced that they are in discussions on the development of a once-daily, fixed-dose combination of three anti-HIV drugs and are also considering certain co-packaging options for the individual products.
Today GE Healthcare officially opens Health Innovation Village, its first health tech startup campus, at its Finnish headquarters with the Minister of Economic Affairs in Finland, Jan Vapaavuori and the Mayor of Helsinki, Jussi Pajunen.
Sunwin International Neutraceuticals, Inc. ("Sunwin") (OTCBB: SUWN) - a worldwide supplier of all-natural, zero-calorie stevia, and WILD Flavors, Inc. ("WILD Flavors") - one of the largest, privately-owned suppliers of natural and health-enhancing ingredients, flavors, colors, and innovative product concepts to the food and beverage industry, have completed the process for U.S. Food and Drug Administration ("FDA") self-affirmed GRAS status for stevia extracts produced by Sunwin and sold worldwide.
As the opioid crisis escalates, the science behind addiction remains poorly understood. To address this need, researchers at University of Utah Health devised a system that allowed zebrafish, a small tropical fish, to self-administer doses of hydrocodone, an opioid commonly prescribed to people for pain.
An antibody drug that targets a surface marker on cancer stem cells could offer a promising new therapeutic approach for treating acute myeloid leukemia (AML), a form of blood cancer that affects an estimated 50,000 people in Saudi Arabia.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph D Ferrara, MD 5612 Easton Rd, Plumsteadville, PA 18949 Ph: (215) 766-8844 | Dr Joseph D Ferrara, MD 5612 Easton Rd, Plumsteadville, PA 18949 Ph: (215) 766-8844 |
News Archive
Bristol-Myers Squibb Company, Gilead Sciences, Inc. and Merck & Co., Inc. have announced that they are in discussions on the development of a once-daily, fixed-dose combination of three anti-HIV drugs and are also considering certain co-packaging options for the individual products.
Today GE Healthcare officially opens Health Innovation Village, its first health tech startup campus, at its Finnish headquarters with the Minister of Economic Affairs in Finland, Jan Vapaavuori and the Mayor of Helsinki, Jussi Pajunen.
Sunwin International Neutraceuticals, Inc. ("Sunwin") (OTCBB: SUWN) - a worldwide supplier of all-natural, zero-calorie stevia, and WILD Flavors, Inc. ("WILD Flavors") - one of the largest, privately-owned suppliers of natural and health-enhancing ingredients, flavors, colors, and innovative product concepts to the food and beverage industry, have completed the process for U.S. Food and Drug Administration ("FDA") self-affirmed GRAS status for stevia extracts produced by Sunwin and sold worldwide.
As the opioid crisis escalates, the science behind addiction remains poorly understood. To address this need, researchers at University of Utah Health devised a system that allowed zebrafish, a small tropical fish, to self-administer doses of hydrocodone, an opioid commonly prescribed to people for pain.
An antibody drug that targets a surface marker on cancer stem cells could offer a promising new therapeutic approach for treating acute myeloid leukemia (AML), a form of blood cancer that affects an estimated 50,000 people in Saudi Arabia.
› Verified 2 days ago
Dr. Scott M Blore, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5612 Easton Rd, Plumsteadville, PA 18949 Phone: 215-766-8844 Fax: 215-766-0733 | |
James P Blore Jr., M D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5612 Easton Rd, Plumsteadville, PA 18949 Phone: 215-766-8844 | |
Inthushi Selvanayagam, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5612 Easton Road, Plumsteadville, PA 18949 Phone: 215-766-8844 Fax: 215-766-0733 | |
Dr. Elizabeth A. Mckenna, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5612 Easton Rd, Plumsteadville, PA 18949 Phone: 215-766-8844 |